glp-1 receptor agonist after roux-en-y gastric bypass Roux en Y hypoglycemia resolves with gastric feeding or reversal: Confirming a non-pancreatic etiology GLP-1 and GIP in Type

In some embodiments, the amount of thickening agent (e.g., a gelling agent) in any formulation described herein is about 0.01%, about 0.02%, about 0.03%, about 0.04%, about 0.05%, about 0.06%, about 0.07%, about 0.08%, about 0.09%, about 0.1%, about 0.2%, about 0.3%, about 0.4%, about 0.5%, about 0.6%, about 0.7%, about 0.8%, about 0.9%, about 1%, about 5%, about 10%, or about 15% of the total weight of the formulation

Increases aerobic threshold due to greater shuttling of ATP from mitochondria

16, 321347.10.1146/annurev.nu.16.070196.001541 268 TrinhK.AndrewsL.KrauseJ.HanakT.LeeD.GelbM.PallanckL

doi: 10.1111/j.1365-2613.2001.iep192.x